Average Co-Inventor Count = 4.42
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cephalon, Inc. (14 from 247 patents)
2. Cephalon France (1 from 20 patents)
3. Teva Sante (1 from 8 patents)
16 patents:
1. 10632119 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
2. 10517852 - Solid forms of bendamustine hydrochloride
3. 10111872 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
4. 10039750 - Solid forms of bendamustine hydrochloride
5. 9623026 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
6. 9533955 - Solid forms of bendamustine hydrochloride
7. 9339502 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
8. 9132128 - Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
9. 8883836 - Solid forms of bendamustine hydrochloride
10. 8759583 - Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
11. 8669279 - Solid forms of bendamustine hydrochloride
12. 8633314 - Forms of a multicyclic compound
13. 8513272 - Forms of a fused pyrrolocarbazole compound
14. 8445524 - Solid forms of bendamustine hydrochloride
15. 8318979 - Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation